AI assistant
Sending…
iBio, Inc. — Director's Dealing 2011
Apr 14, 2011
35045_dirs_2011-04-14_7b608ac9-05f1-4764-b714-792c4aa71b68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2008-08-12
Reporting Person: KAY E GERALD (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6386595 | Indirect |
Footnotes
F1: Includes (i) 819,629 shares of common stock held by EGK LLC, of which the reporting person is the manager and (ii) 1,266,706 shares of common stock owned by Integrated BioPharma, Inc. of which the reporting person is a member of a control group. Shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Kay Sheppard with respect to 169,358 shares of common stock.
More from iBio, Inc.
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 8
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Feb 27
Regulatory Filings
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Interim / Quarterly Report
2026
Feb 10